Tradestie Institutional Equity Comparison Engine

GERN vs ARIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GERN Overall Edge

GERN Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Geron Corp (GERN) driven by superior Valuation, Growth & Margin, Options & Structure while ARIA counters with relative strength in Momentum & Technical. Fundamentally, GERN trades at 48.3x Forward P/E with -7.2% operating margin (+27.4% YoY revenue) versus ARIA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GERN sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner GERN
GERN 48.3x vs ARIA N/M Fwd P/E
Growth & Margin Winner GERN
Op Margin -7.2% vs N/A ยท YoY +27.4% vs N/A
Momentum & Technical Winner ARIA
1Y -18.1% vs -17.0% ยท 52W Pos 9% vs 0%
Options & Structure Winner GERN
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (N/A IV)
GERN NASDAQ
Geron Corp
Pharmaceutical Preparations
$0.94
-2.6% 1D
Market Cap $623.0M
1M Return -19.5%
1Y Return -18.1%
Forward P/E 48.3x
Unified AI Score
54.1 / 100 HOLD
Tech 69.0 Fund 70.0 Flow 71.0 Mom 68.9
ARIA US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap N/A
1M Return -11.55%
1Y Return -16.97%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GERN -18.1% ARIA -16.97% Spread: +19.39 pp (ARIA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GERN TTM Op. Margin: -7.2% ARIA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GERN vs ARIA. Trailing 12-month operating profitability (GERN -7.2% vs ARIA N/A) and valuation multiples (GERN 48.3x vs ARIA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GERN (9) vs ARIA (1)
Institutional Metric GERN ARIA Criterion Row Winner
Market Capitalization Scale $623.0M N/A Larger Scale GERN
Trailing P/E Ratio Valuation 48.3x N/M Lower Multiple GERN
Forward P/E Ratio Valuation 48.3x N/M Lower Multiple GERN
Revenue Growth (YoY) Growth +27.4% N/A Higher Growth GERN
Operating Margin (TTM) Profitability -7.2% N/A Higher Margin GERN
Net Profit Margin Profitability -22.0% N/A Higher Margin GERN
Return on Equity (ROE) Capital Efficiency -20.1% N/A Higher ROE GERN
52-Week Range Position Momentum 9% ($1โ€“$2) 0% ($21โ€“$27) Stronger Trend GERN
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 101% Vol 1.92ฮฒ ยท 43% Vol Lower Realized Risk ARIA
Unified Institutional Score Composite Signal 54.1 / 100 (HOLD) 47.7 / 100 (HOLD) Higher Composite GERN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GERN vs ARIA Buy Guide
GERN BREAKDOWN
72d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live GERN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ARIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GERN nor ARIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.